Farmakoterapia w Psychiatrii i Neurologii

Abstract

2/2025 vol. 41
Case report

Potentiation of antidepressant treatment with racemic ketamine in a patient with an episode of severe depression in the course of bipolar disorder (BD) and a positive history of psychotic mania – a case report

  1. Department of Adult Psychiatry, Medical University of Lodz, Poland; Klinika Psychiatrii Dorosłych Uniwersytetu Medycznego w Łodzi, Łodź, Polska
Farmakoterapia w Psychiatrii i Neurologii 2025
Online publish date: 2026/04/28
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease

Objectives

Although ketamine has become standard treatment for unipolar depression, particularly drug-resistant depression, its use for bipolar depression requires careful consideration of potential benefits and risks, especially in patients with a history of psychotic symptoms.

Case report

In a 52-year-old man with BD, the depressive episode was severe and showed no satisfactory improvement despite multiple changes to pharmacotherapy; therefore, augmentation with intravenous racemic ketamine was considered. However, concern was raised because the patient had experienced a severe manic episode with psychotic features seven years earlier. The patient received racemic ketamine.

Conclusions

A prior history of manic episodes or psychotic symptoms in BD should not automatically preclude ketamine treatment; however, a detailed, individualised risk assessment is essential in each case.

Share
without publication fees
without publication fees